Literature DB >> 11349015

Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

R B Alcantara1, L C Preheim, M J Gentry-Nielsen.   

Abstract

To quantify complement depletion by pneumolysin during Streptococcus pneumoniae bacteremia, cirrhotic and control rats were infected intravenously with one of three isogenic mutant strains of S. pneumoniae expressing different forms of pneumolysin. Outcome measures included clearance of the organisms from the bloodstream, alterations in 50% serum hemolytic complement (CH(50)) activity and complement C3 levels during infection, and serum opsonic capacity at 18 h postinfection. Cirrhotic rats had significantly lower CH(50) and C3 levels than control rats, both before and after infection. However, initial complement levels did not predict bacterial load after 18 h of infection. Changes in CH(50) and C3 levels over the 18-h period correlated with numbers of H+C+ but not H+C- or PLY- organisms in the bloodstream at 18 h postinfection. The sera of cirrhotic rats infected with the H+C+ strain had significantly decreased levels of C3 and showed significantly lower opsonizing activity for S. pneumoniae than sera from H+C+-infected control rats. These studies suggest that under limiting concentrations of complement, the expression of pneumolysin by pneumococci has a significant, negative effect on serum complement levels and reduces serum opsonic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349015      PMCID: PMC98338          DOI: 10.1128/IAI.69.6.3569-3575.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae.

Authors:  M K Hostetter
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

2.  The role of C3 as an opsonin in the early stages of infection.

Authors:  J A Winkelstein; M R Smith; H S Shin
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

3.  Effects of pneumolysin on human polymorphonuclear leukocytes and platelets.

Authors:  M K Johnson; D Boese-Marrazzo; W A Pierce
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

4.  Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.

Authors:  E J Brown; K A Joiner; R M Cole; M Berger
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

Review 5.  Infections in the alcoholic.

Authors:  H G Adams; C Jordan
Journal:  Med Clin North Am       Date:  1984-01       Impact factor: 5.456

6.  Immunologic studies in pneumococcal disease.

Authors:  T H Dee; G Schiffman; M I Sottile; M W Rytel
Journal:  J Lab Clin Med       Date:  1977-06

7.  The critical role of complement in experimental pneumococcal sepsis.

Authors:  S W Hosea; E J Brown; M M Frank
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

Review 8.  The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.

Authors:  E J Brown; S W Hosea; M M Frank
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

9.  High yield micronodular cirrhosis in the rat.

Authors:  E Proctor; K Chatamra
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

10.  The role of opsonins in recovery from experimental pneumococcal pneumonia.

Authors:  J C Guckian; G D Christensen; D P Fine
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

View more
  20 in total

1.  Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.

Authors:  David Verhoeven; Sheldon Perry; Michael E Pichichero
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

2.  The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Authors:  Jose Yuste; Suneeta Khandavilli; Naadir Ansari; Kairya Muttardi; Laura Ismail; C Hyams; Jeffrey Weiser; Timothy Mitchell; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Susana Campuzano; Miriam Moscoso; Fernando González-Camacho; Mirian Domenech; Santiago Rodríguez de Córdoba; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

5.  Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis.

Authors:  Andreas Wellmer; Gregor Zysk; Joachim Gerber; Tammo Kunst; Matthias Von Mering; Stefanie Bunkowski; Helmut Eiffert; Roland Nau
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.

Authors:  Alison R Kerr; Gavin K Paterson; Alan Riboldi-Tunnicliffe; Tim J Mitchell
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 7.  Streptococcus pneumoniae: Invasion and Inflammation.

Authors:  Allister J Loughran; Carlos J Orihuela; Elaine I Tuomanen
Journal:  Microbiol Spectr       Date:  2019-03

Review 8.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.

Authors:  Sherrina N Green; Melissa Sanders; Quincy C Moore; Erin W Norcross; Kathryn S Monds; Armando R Caballero; Larry S McDaniel; Sherrina A Robinson; Chinwendu Onwubiko; Richard J O'Callaghan; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.